Literature DB >> 25230668

GATM locus does not replicate in rhabdomyolysis study.

James S Floyd1, Joshua C Bis1, Jennifer A Brody1, Susan R Heckbert2, Kenneth Rice3, Bruce M Psaty4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25230668      PMCID： PMC4230441          DOI： 10.1038/nature13629

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Cerivastatin and reports of fatal rhabdomyolysis.

Authors:  Judy A Staffa; Jennie Chang; Lanh Green
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

2.  OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis.

Authors:  Bani Tamraz; Hisayo Fukushima; Alan R Wolfe; Rüdiger Kaspera; Rheem A Totah; James S Floyd; Benjamin Ma; Catherine Chu; Kristin D Marciante; Susan R Heckbert; Bruce M Psaty; Deanna L Kroetz; Pui-Yan Kwok
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

3.  Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.

Authors:  Yoshio Kameyama; Keiko Yamashita; Kaoru Kobayashi; Masakiyo Hosokawa; Kan Chiba
Journal:  Pharmacogenet Genomics       Date:  2005-07       Impact factor: 2.089

4.  Cerivastatin, genetic variants, and the risk of rhabdomyolysis.

Authors:  Kristin D Marciante; Jon P Durda; Susan R Heckbert; Thomas Lumley; Ken Rice; Barbara McKnight; Rheem A Totah; Bani Tamraz; Deanna L Kroetz; Hisayo Fukushima; Rüdiger Kaspera; Joshua C Bis; Nicole L Glazer; Guo Li; Thomas R Austin; Kent D Taylor; Jerome I Rotter; Cashell E Jaquish; Pui-Yan Kwok; Russell P Tracy; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

5.  The role of vitamin D and SLCO1B1*5 gene polymorphism in statin-associated myalgias.

Authors:  Randy Linde; Lihong Peng; Manisha Desai; David Feldman
Journal:  Dermatoendocrinol       Date:  2010-04

6.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

Authors:  B M Psaty; M Lee; P J Savage; G H Rutan; P S German; M Lyles
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

7.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Authors:  Deepak Voora; Svati H Shah; Ivan Spasojevic; Shazia Ali; Carol R Reed; Benjamin A Salisbury; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

8.  SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Authors:  E Link; S Parish; J Armitage; L Bowman; S Heath; F Matsuda; I Gut; M Lathrop; R Collins
Journal:  N Engl J Med       Date:  2008-07-23       Impact factor: 91.245

9.  A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

Authors:  Lara M Mangravite; Barbara E Engelhardt; Marisa W Medina; Joshua D Smith; Christopher D Brown; Daniel I Chasman; Brigham H Mecham; Bryan Howie; Heejung Shim; Devesh Naidoo; QiPing Feng; Mark J Rieder; Yii-Der I Chen; Jerome I Rotter; Paul M Ridker; Jemma C Hopewell; Sarah Parish; Jane Armitage; Rory Collins; Russell A Wilke; Deborah A Nickerson; Matthew Stephens; Ronald M Krauss
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

10.  SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.

Authors:  D F Carr; H O'Meara; A L Jorgensen; J Campbell; M Hobbs; G McCann; T van Staa; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2013-08-13       Impact factor: 6.875
View more
  19 in total

Review 1.  Pharmacogenomics of hypertension and heart disease.

Authors:  Meghan J Arwood; Larisa H Cavallari; Julio D Duarte
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

2.  Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites.

Authors:  Xue Bai; Bin Zhang; Ping Wang; Guan-Lei Wang; Jia-Li Li; Ding-Sheng Wen; Xing-Zhen Long; Hong-Shuo Sun; Yi-Bin Liu; Min Huang; Shi-Long Zhong
Journal:  Acta Pharmacol Sin       Date:  2018-06-27       Impact factor: 6.150

3.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

4.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

5.  Mangravite et al. reply.

Authors:  Lara M Mangravite; Barbara E Engelhardt; Matthew Stephens; Ronald M Krauss
Journal:  Nature       Date:  2014-09-18       Impact factor: 49.962

6.  Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.

Authors:  Qian Xiang; Xiao-Dan Zhang; Guang-Yan Mu; Zhe Wang; Zhi-Yan Liu; Qiu-Fen Xie; Kun Hu; Zhuo Zhang; Ling-Yue Ma; Jie Jiang; Yi-Min Cui
Journal:  Eur J Clin Pharmacol       Date:  2020-11-04       Impact factor: 2.953

7.  GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.

Authors:  Jasmine A Luzum; Joseph P Kitzmiller; Paul J Isackson; Changxing Ma; Marisa W Medina; Anees M Dauki; Eduard B Mikulik; Heather M Ochs-Balcom; Georgirene D Vladutiu
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

Review 8.  Identifying genetic modulators of statin response using subject-derived lymphoblastoid cell lines.

Authors:  Yu-Lin Kuang; Elizabeth Theusch; Ronald M Krauss; Marisa W Medina
Journal:  Pharmacogenomics       Date:  2021-04-16       Impact factor: 2.533

9.  Robust Performance of Potentially Functional SNPs in Machine Learning Models for the Prediction of Atorvastatin-Induced Myalgia.

Authors:  Brandon N S Ooi; Ariel F Ying; Yong Zher Koh; Yu Jin; Sherman W L Yee; Justin H S Lee; Samuel S Chong; Jack W C Tan; Jianjun Liu; Caroline G Lee; Chester L Drum
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 10.  Pharmacogenomics of statins: understanding susceptibility to adverse effects.

Authors:  Joseph P Kitzmiller; Eduard B Mikulik; Anees M Dauki; Chandrama Murkherjee; Jasmine A Luzum
Journal:  Pharmgenomics Pers Med       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.